Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.
Covance is dedicated to advancing healthcare and delivering Solutions Made Real®
With precision delivery of the largest volume of drug development data on the planet, we can help you identify new approaches and anticipate tomorrow’s challenges. Learn more about our history and services.
What is your drug development goal?
Experience drug development your way with solutions distinctly for the nimble biotech venture.
Real-Time Data. Real-World Impact.
Combining four unique data sets with our therapeutic and functional expertise, Covance can impact protocol design and feasibility, optimal site selection, and patient recruitment.
Solutions to minimize risk and optimize your trial designs
Discover how our innovation, commitment and expertise can accelerate your complex immuno-oncology drug development
Access the latest in scientific and patient centric solutions for your Rare Disease and Orphan Drug Development Program
Visualizing datasets and previewing SEND 3.1
Join Covance SEND leaders, Megan Basuman and Mikayla Simons at their upcoming Society of Toxicology session in March on how to visualize your data points and be prepared for SEND 3.1.
Clinical Trial Monitoring
Xcellerate® CRA Dashboard: The Future of Monitoring
Learn how this award winning novel solution is improving site quality and performance through monitoring efficiency.
Understanding a No-Deal Brexit & Your Device Development
In just a few days, the United Kingdom might be considered a "3rd country" by medical device regulations if a no-deal Brexit happens. What are the implications for your devices in development or already on the market? Read the post.
Analytical methods for bioanalysis
Check out our recently updated nonproprietary assay list featuring more than 330 compounds.
End-to-end drug & diagnostic development support for a new immuno-oncology agent
Find out how Covance/LabCorp helped a prominent pharmaceutical company enable a faster, more effective launch of their immuno-oncology drug.
Take a tour of the York UK GMP BioCMC Lab
See the full range of BioPharm CMC analytical services available including GMP-certified testing.
Enhancing Study Design with a Real World Evidence Tool
Real World Evidence (RWE) has the potential to transform our industry, but there are a number of challenges when it comes to planning a study and execution. Learn about a powerful new tool that can help improve your RWE study design and register for our webinar today.
Clinical Data and Informatics
Explore the Xcellerate® Informatics Suite
Successful clinical trials begin and end with the RIGHT data. Uncover new possibilities for your clinical trials with Xcellerate®, a fully integrated informatics platform. ONE comprehensive platform. UNPARALLELED RESULTS.
Bioanalysis Education Center: Covance leads the way in bioanalytical capabilities and solutions, igniting innovation with exceptional science and timely answers.
Access the latest scientific posters, list of non-proprietary/generic assays, publications and info sheets.
Rare Disease and Orphan Drugs: accelerate complex studies globally
A range of individual approaches can be integrated to accelerate your progress of complex rare disease studies across the world. Learn how to address key development challenges.
Tour the Interactive, Virtual Safety Facility
See for yourself, through the magic of virtual technology, why more than 90% of the clinical studies placed in our Greenfield, Indiana, (USA) facility serve nimble and progressive biopharma ventures in this interactive tour. Learn more.